Ocean Biomedical, Inc.

Aesther Healthcare Acquisition Corp. (Nasdaq: AEHA), sponsored by Aesther Healthcare Sponsor LLC, completed its initial public offering in 2021 targeting the healthcare and biopharmaceutical sector. The blank-check company entered into a definitive business combination agreement with Ocean Biomedical, Inc., a Rhode Island-based biopharmaceutical company developing treatments across oncology, pulmonary disease, and infectious disease. The September 2022 8-K filing reflects activity during the de-SPAC transaction process, ahead of the combination's eventual close in early 2023. Ocean Biomedical operates as a clinical-stage company translating research from Brown University into therapeutic candidates. For full filing history, deal timeline, and sponsor data on AEHA, sign up for SpacDesk at spacdesk.com.